CRBP
#3589
Corbus Pharmaceuticals Holdings, Inc. - Common Stock
10.9 1 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.98%
Monthly Change
+22.58%
6 month change
+28.66%
Year Change
-34.28%
Previous Close
11.1 3
Open
10.9 1
Low
10.9 1
High
10.9 1
Volume
31
Financials
- Market Capitalization 211.01 M
- Employee 36
- Founded 2009
- CEO N/A
- Website www.corbuspharma.com
- Headquarter Delaware, United States
- FIGI BBG0078PJKQ7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.38
Price to sales ratio
18.82
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3583 |  NBP NovaBridge Biosciences - American Depositary Shares | 1.84 USD | -2.65% | -8.46% | +12.88% | -59.20% | 212.30 M USD | ||
| 3588 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.92 USD | -3.63% | -7.89% | +37.74% | +116.30% | 211.17 M USD | ||
| 3591 |  ANTX AN2 Therapeutics, Inc. - Common Stock | 5.58 USD | -2.79% | -4.12% | +10.93% | +398.21% | 210.57 M USD | ||
| 3592 |  IMUX Immunic, Inc. - Common Stock | 15.40 USD | -5.52% | -6.55% | +18.46% | +1778.05% | 210.12 M USD |
Frequently asked questions about Corbus Pharmaceuticals Holdings, Inc.
What is the Corbus Pharmaceuticals Holdings, Inc. stock price today?
The current price of Corbus Pharmaceuticals Holdings, Inc. (CRBP) is 10.91. Over the past 24 hours, the stock has changed by -1.98%. Follow the CRBP chart for real-time price dynamics.
What is the stock ticker of Corbus Pharmaceuticals Holdings, Inc.?
Corbus Pharmaceuticals Holdings, Inc. trades under the ticker CRBP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Corbus Pharmaceuticals Holdings, Inc. stock going up?
CRBP has changed by +6.96% over the last week, +22.58% over the last month, and -34.28% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Corbus Pharmaceuticals Holdings, Inc.?
Corbus Pharmaceuticals Holdings, Inc. currently has a market capitalization of 211.01 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Corbus Pharmaceuticals Holdings, Inc. earnings last quarter?
Last quarter, Corbus Pharmaceuticals Holdings, Inc. reported earnings of -1.81 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Corbus Pharmaceuticals Holdings, Inc. revenue for the last quarter?
Corbus Pharmaceuticals Holdings, Inc. reported quarterly revenue of 1.15 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Corbus Pharmaceuticals Holdings, Inc. net income for the last quarter?
Corbus Pharmaceuticals Holdings, Inc. reported net income of -35.04 M for the last quarter. The previous quarter showed -22.97 M, which means net income changed by -52.54%.
How many employees does Corbus Pharmaceuticals Holdings, Inc. have?
As of the latest available data, Corbus Pharmaceuticals Holdings, Inc. has 36 employees. Workforce size can provide additional context about the company's scale and operations.
What is Corbus Pharmaceuticals Holdings, Inc. EBITDA?
Corbus Pharmaceuticals Holdings, Inc. EBITDA is -34.99 M, and its EBITDA margin is -3 031.72%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Corbus Pharmaceuticals Holdings, Inc. stock?
You can buy Corbus Pharmaceuticals Holdings, Inc. (CRBP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Corbus Pharmaceuticals Holdings, Inc. stock?
Investing in Corbus Pharmaceuticals Holdings, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRBP chart and related analysis on metatrader.com as part of your research.